1 study on Ghrh r agonist mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
These findings suggest that GHRH agonists like sermorelin or its analogs could be a promising therapeutic strategy for the early stages of diabetic retinopathy. By targeting antioxidant and anti-inflammatory pathways,…